Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Bhatia

Showing results (161-170 of 220) with videos related to

Pageof 22
Sort By:
The Journal of Clinical Investigation|June 8, 2011
The LRF transcription factor regulates mature B cell development and the germinal center response in miceNagisa Sakurai, Manami Maeda, Sung-Uk Lee, et al.
Cancer|October 9, 2024
Self-rated health is an independent predictor of subsequent late mortality after blood or marrow transplantation: A Blood or Marrow Transplant Survivor Study reportNora Balas, Joshua Richman, Wendy Landier, et al.
Blood Advances|September 8, 2023
Risky health behaviors and subsequent late mortality after blood or marrow transplantation: a BMTSS reportNora Balas, Joshua Richman, Wendy Landier, et al.
BMC Pulmonary Medicine|July 12, 2025
Annual household income and chronic pulmonary conditions in long-term survivors of blood or marrow transplantation: a BMTSS reportTrisha M Parekh, Rekha Ramachandran, Young-Il Kim, et al.
Cancer|August 15, 2019
Late mortality after bone marrow transplant for chronic myelogenous leukemia in the context of prior tyrosine kinase inhibitor exposure: A Blood or Marrow Transplant Survivor Study (BMTSS) reportJessica Wu, Yanjun Chen, Lindsey Hageman, et al.
Blood|September 14, 2013
T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemiaArmen Mardiros, Cedric Dos Santos, Tinisha McDonald, et al.
JAMA Dermatology|December 18, 2024
Incidence of and Risk Factors for Cutaneous Malignant Neoplasms After Blood or Marrow TransplantKristy K Broman, Qingrui Meng, Anna Holmqvist, et al.
Blood|April 2, 2013
Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cellsElisabeth Bolton-Gillespie, Mirle Schemionek, Hans-Ulrich Klein, et al.
Blood Advances|February 1, 2023
Risk of COVID-19 infection in long-term survivors of blood or marrow transplantation: a BMTSS reportEmily E Johnston, Qingrui Meng, Lindsey Hageman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2024
Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin LymphomaChengcheng Yan, Melissa A Richard, Christopher J Gibson, et al.
Pageof 22

Showing results (161-170 of 220) with videos related to

Sort By:
Pageof 22
The Journal of Clinical Investigation|June 8, 2011
The LRF transcription factor regulates mature B cell development and the germinal center response in miceNagisa Sakurai, Manami Maeda, Sung-Uk Lee, et al.
Cancer|October 9, 2024
Self-rated health is an independent predictor of subsequent late mortality after blood or marrow transplantation: A Blood or Marrow Transplant Survivor Study reportNora Balas, Joshua Richman, Wendy Landier, et al.
Blood Advances|September 8, 2023
Risky health behaviors and subsequent late mortality after blood or marrow transplantation: a BMTSS reportNora Balas, Joshua Richman, Wendy Landier, et al.
BMC Pulmonary Medicine|July 12, 2025
Annual household income and chronic pulmonary conditions in long-term survivors of blood or marrow transplantation: a BMTSS reportTrisha M Parekh, Rekha Ramachandran, Young-Il Kim, et al.
Cancer|August 15, 2019
Late mortality after bone marrow transplant for chronic myelogenous leukemia in the context of prior tyrosine kinase inhibitor exposure: A Blood or Marrow Transplant Survivor Study (BMTSS) reportJessica Wu, Yanjun Chen, Lindsey Hageman, et al.
Blood|September 14, 2013
T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemiaArmen Mardiros, Cedric Dos Santos, Tinisha McDonald, et al.
JAMA Dermatology|December 18, 2024
Incidence of and Risk Factors for Cutaneous Malignant Neoplasms After Blood or Marrow TransplantKristy K Broman, Qingrui Meng, Anna Holmqvist, et al.
Blood|April 2, 2013
Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cellsElisabeth Bolton-Gillespie, Mirle Schemionek, Hans-Ulrich Klein, et al.
Blood Advances|February 1, 2023
Risk of COVID-19 infection in long-term survivors of blood or marrow transplantation: a BMTSS reportEmily E Johnston, Qingrui Meng, Lindsey Hageman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2024
Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin LymphomaChengcheng Yan, Melissa A Richard, Christopher J Gibson, et al.
Pageof 22